The purpose of this study is to evaluate the bioequivalence of a fixed dose combination
tablet of canagliflozin and metformin immediate release (IR) in comparison with the
individual components of canagliflozin and metformin IR.
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01463774
Ages eligible for Study
19 Years to 55 Years
Genders eligible for Study
Accepts Healthy Volunteers
Body mass index (BMI) between 18.5 and 30 kg/m² inclusive and a body weight of not less than 50 kg
History of or current medical illness, abnormal values for hematology or clinical chemistry laboratory tests, or abnormal physical examination, vital signs or 12-lead electrocardiogram (ECG) deemed to be clinically significant by the Investigator
All locations for NCT01463774
United States (1)
Lincoln, Nebraska, United States
Nebraska, United States
View full eligibility
Tris trial is registered with FDA with number: NCT01463774. The sponsor of the trial is Janssen Research & Development, LLC and it is looking for 74 volunteers for the current phase.
Official trial title: Pivotal BE CANA/MET IR FDC - Low Strength
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.